US approval for laser angioplasty catheters:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Spectranetics' new line of single-use catheters for laser coronary angioplasty. The Vitesse Cos catheters are designed to remove plaque from the coronary arteries - in trials they improve debulking efficiency by up to 62% compared with earlier devices, said Colorado Springs, Colarado-based Spectranetics. The PMA means that the company could begin selling the products in the second quarter of 2000.